Michael Chi - 10 Oct 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Reporting relationship: Chief Commercial Officer
Issuer ticker: HIMS
Reported as of: 10 Oct 2025
Net transaction value: -$46,287
SEC form: 4
Accepted by SEC: 14 Oct 2025, 16:17:51 UTC
Prior SEC filing: 02 Oct 2025
Next SEC filing: 02 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Mather, Attorney-in-Fact for Michael Chi

Key filing fact

Michael Chi filed Form 4 for Hims & Hers Health, Inc. (HIMS) on 14 Oct 2025.

Key facts

This page summarizes Michael Chi's Form 4 filing for Hims & Hers Health, Inc. (HIMS).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Oct 2025, 16:17.

Change

Previous filing in this sequence was filed on 02 Oct 2025.
Current net transaction value: -$46,287.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001965903 Primary reporting owner

Chi Michael

Relationship: Chief Commercial Officer
Address: 2269 CHESTNUT STREET, #523, SAN FRANCISCO
Signature: /s/ Kimberly Mather, Attorney-in-Fact for Michael Chi
Signature date: 14 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIMS transaction

Class A Common Stock

Options Exercise

Transaction value: $6,138
Shares: +900
Change %: +0.31%
Price: $6.82
Shares after: 292,339
Date: 10 Oct 2025
Ownership: Direct
Footnotes: F1

HIMS transaction

Class A Common Stock

Sale

Transaction value: $52,425
Shares: -900
Change %: -0.31%
Price: $58.25
Shares after: 291,439
Date: 10 Oct 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIMS transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -900
Change %: -0.77%
Price: $0.000000
Shares after: 115,362
Date: 10 Oct 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 900
Exercise price: $6.82
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

Footnote F2

The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.